Evidence map›Paper›PMID 33573196›Full record

ArticleBiology2021

Plasma Concentrations of Extracellular Vesicles Are Decreased in Patients with Post-Infarct Cardiac Remodelling.

Aleksandra Gąsecka, Kinga Pluta, Katarzyna Solarska, Bartłomiej Rydz, Ceren Eyileten, Marek Postula, Edwin van der Pol, Rienk Nieuwland, Monika Budnik, Janusz Kochanowski and 6 more

Open access · goldAbstract read
In one paragraph

Article in Biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Aleksandra Gąsecka1st Chair and Department of Cardiology, Medical University of Warsaw, 02-097 Warsaw, Poland.ORCID 0000-0001-5083-7587
Kinga Pluta1st Chair and Department of Cardiology, Medical University of Warsaw, 02-097 Warsaw, Poland.
Katarzyna Solarska1st Chair and Department of Cardiology, Medical University of Warsaw, 02-097 Warsaw, Poland.
Bartłomiej Rydz1st Chair and Department of Cardiology, Medical University of Warsaw, 02-097 Warsaw, Poland.
Ceren EyiletenDepartment of Experimental and Clinical Pharmacology, Centre for Preclinical Research and Technology, Medical University of Warsaw, 02-091 Warsaw, Poland.
Marek PostulaDepartment of Experimental and Clinical Pharmacology, Centre for Preclinical Research and Technology, Medical University of Warsaw, 02-091 Warsaw, Poland.ORCID 0000-0002-7826-4458
Edwin van der PolLaboratory of Experimental Clinical Chemistry, Amsterdam University Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Rienk NieuwlandLaboratory of Experimental Clinical Chemistry, Amsterdam University Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.ORCID 0000-0002-5671-3400
Monika Budnik1st Chair and Department of Cardiology, Medical University of Warsaw, 02-097 Warsaw, Poland.
Janusz Kochanowski1st Chair and Department of Cardiology, Medical University of Warsaw, 02-097 Warsaw, Poland.
Miłosz J Jaguszewski1st Department of Cardiology, Medical University of Gdańsk, 80-952 Gdansk, Poland.
Łukasz SzarpakMaria Sklodowska-Curie Bialystok Oncology Center, 15-027 Bialystok, Poland.ORCID 0000-0002-0973-5455
Tomasz Mazurek1st Chair and Department of Cardiology, Medical University of Warsaw, 02-097 Warsaw, Poland.ORCID 0000-0002-3693-8741
Agnieszka Kapłon-Cieślicka1st Chair and Department of Cardiology, Medical University of Warsaw, 02-097 Warsaw, Poland.
Grzegorz Opolski1st Chair and Department of Cardiology, Medical University of Warsaw, 02-097 Warsaw, Poland.ORCID 0000-0003-4744-2554
Krzysztof J Filipiak1st Chair and Department of Cardiology, Medical University of Warsaw, 02-097 Warsaw, Poland.ORCID 0000-0002-6563-0877
Medical University of Warsaw · PLAmsterdam University Medical Centers · NLGdańsk Medical University · PLMedical University of Białystok · PL

Funding

Narodowe Centrum Nauki 2017/25/N/NZ5/00545Narodowe Centrum Nauki 2018/31/N/NZ7/02260Nederlandse Organisatie voor Wetenschappelijk Onderzoek VENI 15924
6 · The paper itself

Abstract

Background, the mechanisms underlying left ventricular remodelling (LVR) after acute myocardial infarction (AMI) remain obscure. In the course of AMI, blood cells and endothelial cells release extracellular vesicles (EVs). We hypothesized that changes in EV concentrations after AMI may underlie LVR. Methods, plasma concentrations of EVs from endothelial cells (CD146+), erythrocytes (CD235a+), leukocytes (CD45+), platelets (CD61+), activated platelets (P-selectin+), and EVs exposing phosphatidylserine after AMI were determined by flow cytometry in 55 patients with the first AMI. LVR was defined as an increase in left ventricular end-diastolic volume by 20% at 6 months after AMI, compared to baseline. Results, baseline concentrations of EVs from endothelial cells, erythrocytes and platelets were lower in patients who developed LVR (

Indexed as

acute myocardial infarctionextracellular vesiclesflow cytometryheart failureleft-ventricular remodelling

Identifiers

PMID33573196
PMCPMC7910841
OpenAlexW3126708636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.